Related Experiment Video
Updated: Mar 31, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Internalization and Recycling of the HER2 Receptor on Human Breast Adenocarcinoma Cells Treated with Targeted
O N Shilova1, G M Proshkina1, E N Lebedenko1
1Shemyakin/Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Miklukho-Maklaya Str., 16/10, Moscow, 117997, Russia.
Abstract:
Design and evaluation of new high-affinity protein compounds that can selectively and efficiently destroy human cancer cells are a priority research area in biomedicine. In this study we report on the ability of the recombinant phototoxic protein DARPin-miniSOG to interact with breast adenacarcinoma human cells overexpressing the extracellular domain of human epidermal growth factor receptor 2 (HER2). It was found that the targeted phototoxin DARPin-miniSOG specifically binds to the HER2 with following internalization and slow recycling back to the cell membrane. An insight into the role of DARPin-miniSOG in HER2 internalization could contribute to the treatment of HER2-positive cancer using this phototoxic protein.
Insights
Researchers developed a phototoxic protein, DARPin-miniSOG, that targets and enters HER2-positive breast cancer cells. This protein
Area of Science:
- Biomedicine
- Molecular Biology
- Cancer Research
Background:
- Developing targeted cancer therapies is crucial.
- High-affinity protein compounds can selectively destroy cancer cells.
- HER2 overexpression is common in breast adenocarcinomas.
Purpose of the Study:
- To evaluate the recombinant phototoxic protein DARPin-miniSOG.
- To assess its interaction with HER2-positive breast cancer cells.
- To understand its potential in cancer treatment.
Main Methods:
- Designing and evaluating high-affinity protein compounds.
- Utilizing recombinant phototoxic protein DARPin-miniSOG.
- Studying interactions with breast adenocarcinoma cells overexpressing HER2.
Main Results:
- DARPin-miniSOG specifically binds to HER2.
- The protein undergoes internalization into cancer cells.
- Slow recycling of DARPin-miniSOG to the cell membrane was observed.
Conclusions:
- DARPin-miniSOG shows specific binding and internalization in HER2-positive cancer cells.
- Understanding DARPin-miniSOG's role in HER2 internalization is key.
- This phototoxic protein holds promise for treating HER2-positive cancers.
More Related Videos
11:52Analysis of Targeted Viral Protein Nanoparticles Delivered to HER2+ Tumors
Published on: June 18, 2013
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle